API major, Lasa Supergenerics Ltd recently announced to Support India's Fight against Corona Virus and pledged support to donate 25000 doses of "Favipiravir" drug to cure Covid19 upon successful clinical trials and requisite approval from Government. Apart from this Company has already extended monetary support to Prime Minister Relief Fund and Chief Minister Relief Fund today.
Commenting on the development, Dr Omkar Herlekar, Chairman- Lasa Supergenerics Limited, said In my opinion "Favipiravir" shall result in one of the best steps in Treatment of COVID19 since Health and safety of our countrymen is of pristine importance Our company today pledged to Donate minimum 25000 doses of "Favipiravir" after success in clinical trials and all statutory nod.
Shares of Lasa Supergenerics Ltd was last trading in BSE at Rs.31.05 as compared to the previous close of Rs. 29.65. The total number of shares traded during the day was 36221 in over 91 trades.
The stock hit an intraday high of Rs. 31.1 and intraday low of 30. The net turnover during the day was Rs. 1123150.